Back to search

Angelini Pharma Uk-I Limited

13473950

active
Private Limited Company
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)

Details

6TH FLOOR NAPIER HOUSE, LONDON, WC1V 6AZ
Incorporated 23/06/2021

Compliance

Last accounts

31/12/2024

full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 22/06/2025

Due 06/07/2026

On track

Industry

21100
Manufacture of basic pharmaceutical products
21200
Manufacture of pharmaceutical preparations
46460
Wholesale of pharmaceutical goods

Officers

Fras Anna Kristina Andersson

director · Since 01/01/2025

Swedish

Jetmir Daku

director · Since 01/01/2026

Swiss

Former

Pierluigi Antonelli

director · Resigned 28/10/2022

Luigi Cianci

director · Resigned 29/04/2022

Stuart Mulheron

director · Resigned 01/01/2025

Azra Topaloglu

director · Resigned 01/01/2026

CompanyRankvs 270+ SIC 21100 peers
78

Financial strength96th percentile among SIC peers · 24/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 3.22× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2023

Net Worth

£6.3M

Balance sheet strength

Cash

£2.2M

Cash in the bank

Net Current Assets

£6.3M

Working capital

Current Assets

£9.1M

Current Liabilities

£2.8M

Fixed Assets

£29k

Debtors

£137k

24avg. employees

Tax at Year End

Corp tax£695k

Balance Sheet

Assets less current liabilities£6.3M
Prepared with Caseware UK (AP4) 2023.0.135

EstimatesDerived

YearCurrent Ratio
20233.22

Derived from filed accounts. Not audited figures.